CClinicalTrials.gg
RecruitingNCT02533245THESUpdated Jul 12, 2024

Transplantoux Health Evaluation Study

An interventional study of Home-based indiviualized exercise training program and Supervised group training sessions in Quality of Life, sponsored by Universitaire Ziekenhuizen KU Leuven. Recruiting at 1 site in Belgium. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-12.

Sponsored by Universitaire Ziekenhuizen KU Leuven · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 9 months ago, but the record still lists the study as recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Non-randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The primary aim is to evaluate the short- and long-term effect of the 'Transplantoux' exercise training intervention in solid organ transplant recipients with matched control sample of transplant recipients in view of selected Patient Reported Outcomes (PRO), i.e. health-related quality-of-life (HRQOL), psychosocial and behavioral variables, using a quasi-experimental design.

Read the detailed description

During the last decades advances in solid organ transplantation, like e.g. organ preservation, surgical techniques and immunosuppressive treatment have contributed to improvements in postoperative survival. Thereby, solid organ transplantation (Tx) has moved from experimental treatment towards a clinical reality and a life-saving surgery, offering most patients a good long-term survival. However, further improvement in long-term survival remains a major challenge.

It is increasingly recognized that non-pharmacological interventions hold the potential to improve long-term outcomes in transplantation as evidence shows that health behavior has been independently associated with transplant outcome (e.g. physical activity, non-smoking, medication adherence). Furthermore, exercise training interventions show positive outcome in a number of populations and limited research in transplantation shows positive outcomes in view of exercise capacity, muscle strength, cardiopulmonary variables and body composition. However, there is a lack of research that evaluates exercise training interventions in view of patient reported outcomes (PROs) in transplant recipients.

In the University Hospitals of Leuven (Belgium) a project named 'Transplantoux' has been launched to enhance physical activity and exercise capacity in transplant recipients. Transplant recipients participate in the 'Transplantoux' exercise training intervention for 6-months with the ultimate goal to cycle or hike up the Mont Ventoux (France) (distance: 25.9 km, mean slope: 4.4%). Extending on a previous safety feasibility study in which we demonstrated that selected Transplant recipients can safely participate in an intense exercise program and that exercise capacity was significantly improved after training. The primary aim of the current study is to evaluate the short- and long-term effect of the 'Transplantoux' intervention in view of selected Patient Reported Outcomes (PROs), i.e. perceived health-related quality-of-life, depressive symptomatology, stress and well-being, physical activity, social contacts and social support, and barriers and motivators to exercise.

The Transplantoux Health Evaluation Study (THES) uses a quasi-experimental design with three convenience samples: 1) a convenience sample of solid organ transplant (Tx)-recipients participating in the Transplantoux exercise training intervention, 2) matched control sample of Tx-recipients not participating in the Transplantoux exercise intervention, and 3) and a convenience sample of healthy controls participating in the Transplantoux exercise intervention. Selected PROs will be assessed using validated self-reported questionnaire. Data collection will be performed at baseline, 3 months (in the middle of the training intervention), 6 months (immediately following the intervention), 9 months (3 months follow-up period) and 12 months (6 months follow-up period).

02

Conditions studied

  • Quality of Life

Keywords

  • Exercise Training
  • Quality of Life
  • Patient Reported Outcomes
  • Organ Transplantation
03

In context

Lead sponsor

Universitaire Ziekenhuizen KU Leuven is the lead sponsor of 928 studies on the registry; 261 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

  1. Tx exercise group:

    Inclusion Criteria:

    • Tx recipient (heart, lung, liver, kidney, pancreas or small bowel)
    • Age between 18 - 70 years
    • More than 1y post-transplant

    Exclusion Criteria:

    • Rejection last 6 months
    • Severe co-morbidity
    • Contra-indication for severe exercise (e.g. cardiovascular disease)
    • Insufficient knowledge of Dutch language
  2. Tx matched control group

    Inclusion Criteria:

    • Tx recipient (heart, lung, liver, kidney, pancreas or small bowel)
    • Age between 18 - 70 years
    • More than 1y post-transplant

    Exclusion Criteria:

    • Rejection last 6 months
    • Insufficient knowledge of Dutch language
  3. Healthy exercise group:

Inclusion Criteria:

  • Age between 18 - 70 years

Exclusion Criteria:

  • Contra-indication for severe exercise
  • Insufficient knowledge of Dutch language
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
500 participants (estimated)

Study arms

  • Experimental
    Tx exercise group

    Convenience sample of solid organ transplant recipients (heart, kidney, lung, liver, pancreas, small bowel) participating in the Transplantoux exercise training intervention. Intervention: * Home-based individualized exercise training program * Supervised group training sessions * Climb of the Mont Ventoux

    Other: Home-based indiviualized exercise training program · Other: Supervised group training sessions · Other: Climb of the Mont Ventoux

  • No intervention
    Tx matched control group

    Controls are retrieved from the Leuven University Hospital heart, kidney, lung, liver, pancreas, small bowel transplant database and matched (1:4 matching) based on type of transplant, gender, age and time since transplant.

  • Experimental
    Healthy exercise group

    Convenience sample of health care providers (e.g. doctor, paramedic or medical companion involved in care programs for organ Tx) and patient's family members and friends participating in the Transplantoux exercise training intervention. Intervention: * Supervised group training sessions * Climb of the mont ventoux

    Other: Supervised group training sessions · Other: Climb of the Mont Ventoux

Interventions

  • OtherHome-based indiviualized exercise training program

    Based on these results of the cardiopulmonary exercise test (CPET) on a cycle ergometer, an individualized training program (cycling/hiking) is prescribed by a physical therapist for 6 months (3x/week, ≥30min/session).

  • OtherSupervised group training sessions

    7 supervised group training sessions (cycling/hiking) are organized by a physiotherapist

  • OtherClimb of the Mont Ventoux

    Cycle or hike up the Mont Ventoux (25.7 km, average slope 4.5%)

06

What researchers measure

Primary outcomes

  1. Change in PROs (i.e. perceived quality of life, depressive symptomatology, stress and well-being, physical activity, and social contacts and support) in the Tx exercise group compared with Tx matched control group

    Time frame: baseline, 3, 6, 9 and 12 months

Secondary outcomes

  1. Change in PROs (i.e. perceived quality of life, depressive symptomatology, stress and well-being, physical activity, and social contacts and support) in Tx exercise group compared with healthy exercise group

    Time frame: baseline, 3, 6, 9 and 12 months

  2. Compare PROs (i.e. perceived quality of life, depressive symptomatology, stress and well-being, physical activity, and social contacts and support) of the three groups with a representative sample of the Belgian population

    Time frame: baseline

  3. Compare perceived barriers and motivators for physical exercise/activity in the three groups

    Time frame: 12 months

07

Study locations

1 of 1 sites recruiting
  • University Hospitals Leuven
    Leuven, 3000, Belgium
    • Laurens Ceulemans, MD · Sub investigator
    • Sabina De Geest, RN, PhD · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02533245
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Collaborators
University of Basel
Responsible party
Sponsor
First posted
Aug 26, 2015
Start date
Jan 2015
Primary completion
Jan 2025 (estimated)
Completion
Jan 2025 (estimated)
Last update
Jul 12, 2024

Study contacts

Evi Masschelein, PhD
Contact
evi.masschelein@kuleuven.be
+3216372622
Ceulemans
Contact
Diethard Monbaliu, MD, PhD
principal investigator · University Hospital Leuven, Abdominal Transplant Surgery

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion